Antidiabetic medications and the risk of colorectal cancer in patients with diabetes mellitus: a systematic review and meta-analysis
- PMID: 24042261
- DOI: 10.1158/1055-9965.EPI-13-0429
Antidiabetic medications and the risk of colorectal cancer in patients with diabetes mellitus: a systematic review and meta-analysis
Abstract
Background: Antidiabetic medications (ADM) may modify colorectal cancer risk in patients with diabetes mellitus. We performed a systematic review and meta-analysis, evaluating the effect of metformin, thiazolidinediones (TZD), sulfonylureas, and insulin on colorectal cancer risk in diabetic patients.
Methods: We conducted a systematic search of multiple bibliographic databases, up to September 2012, for articles that evaluated exposure to metformin, TZD, sulfonylureas, and insulin, reported colorectal cancer risk in patients with diabetes mellitus, and reported OR or provided data for their estimation. Summary OR estimates with 95% confidence intervals (CI) were estimated using the random-effects model.
Results: Fifteen studies reporting 13,871 cases of colorectal cancer in 840,787 patients with diabetes mellitus were included. Meta-analysis of observational studies showed an 11% reduction in colorectal cancer risk associated with metformin use (n = 9 studies; OR, 0.89; 95% CI, 0.81-0.99), whereas TZD use was not associated with colorectal cancer risk (n = 5 studies; OR, 0.96; 95% CI, 0.87-1.05). Conversely, a trend toward higher colorectal cancer risk was observed with sulfonylurea (n = 7 studies; OR, 1.11; 95% CI, 0.97-1.26) and insulin (n = 9 studies; OR, 1.33; 95% CI, 0.91-1.94) use, although these associations were not statistically significant. There was considerable heterogeneity across studies, partly explained by study location and adjustment for concomitant use of other ADMs. Post-hoc analysis of randomized controlled trials did not reveal any significant association between ADM and colorectal cancer risk.
Conclusions: Meta-analysis of published studies supports a protective association between metformin use and colorectal cancer risk in patients with diabetes mellitus.
Impact: Clinical trials on the chemopreventive effect of metformin against colorectal cancer are warranted.
©2013 AACR.
Similar articles
-
Thiazolidinediones and risk of colorectal cancer in patients with diabetes mellitus: A meta-analysis.Saudi J Gastroenterol. 2018 Mar-Apr;24(2):75-81. doi: 10.4103/sjg.SJG_295_17. Saudi J Gastroenterol. 2018. PMID: 29637913 Free PMC article. Review.
-
Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis.Am J Gastroenterol. 2013 Jun;108(6):881-91; quiz 892. doi: 10.1038/ajg.2013.5. Epub 2013 Feb 5. Am J Gastroenterol. 2013. PMID: 23381014 Review.
-
Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis.Am J Gastroenterol. 2013 Apr;108(4):510-9; quiz 520. doi: 10.1038/ajg.2013.7. Epub 2013 Feb 12. Am J Gastroenterol. 2013. PMID: 23399556 Review.
-
Anti-diabetic medications do not influence risk of lung cancer in patients with diabetes mellitus: a systematic review and meta-analysis.Asian Pac J Cancer Prev. 2014;15(16):6863-9. doi: 10.7314/apjcp.2014.15.16.6863. Asian Pac J Cancer Prev. 2014. PMID: 25169538 Review.
-
Antidiabetic Medications and the Risk of Endometrial Cancer in Patients.Gynecol Obstet Invest. 2019;84(5):455-462. doi: 10.1159/000497202. Epub 2019 Feb 26. Gynecol Obstet Invest. 2019. PMID: 30808843
Cited by
-
Effect of diabetes mellitus type 2 and sulfonylurea on colorectal cancer development: a case-control study.BMC Gastroenterol. 2024 Oct 28;24(1):382. doi: 10.1186/s12876-024-03477-4. BMC Gastroenterol. 2024. PMID: 39465354 Free PMC article.
-
Medication use and risk of proximal colon cancer: a systematic review of prospective studies with narrative synthesis and meta-analysis.Cancer Causes Control. 2021 Oct;32(10):1047-1061. doi: 10.1007/s10552-021-01472-8. Epub 2021 Jul 5. Cancer Causes Control. 2021. PMID: 34224060 Free PMC article. Review.
-
Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance).Oncologist. 2016 Dec;21(12):1509-1521. doi: 10.1634/theoncologist.2016-0153. Epub 2016 Nov 23. Oncologist. 2016. PMID: 27881709 Free PMC article.
-
Development of a Web-Based System for Exploring Cancer Risk With Long-term Use of Drugs: Logistic Regression Approach.JMIR Public Health Surveill. 2021 Feb 15;7(2):e21401. doi: 10.2196/21401. JMIR Public Health Surveill. 2021. PMID: 33587043 Free PMC article.
-
Thiazolidinediones and risk of colorectal cancer in patients with diabetes mellitus: A meta-analysis.Saudi J Gastroenterol. 2018 Mar-Apr;24(2):75-81. doi: 10.4103/sjg.SJG_295_17. Saudi J Gastroenterol. 2018. PMID: 29637913 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical